{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:50:12Z","timestamp":1782233412068,"version":"3.54.5"},"reference-count":350,"publisher":"The Endocrine Society","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1194576"],"award-info":[{"award-number":["APP1194576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Monash University Research Training Program"},{"name":"Centre for Research Excellence","award":["APP2024615"],"award-info":[{"award-number":["APP2024615"]}]},{"DOI":"10.13039\/501100014643","name":"Baker Heart and Diabetes Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015971","name":"Hudson Institute of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015971","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victorian Government's Operational Infrastructure Scheme"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary aldosteronism (PA) is the most common endocrine cause of high blood pressure, affecting more than 1 in 10 people with hypertension. Once considered rare, it has become a public health priority because undiagnosed PA confers significantly higher risks of stroke, myocardial infarction, heart failure, chronic kidney disease, and impaired quality of life. As a result, international guidelines now recommend routine screening for PA in all adults with hypertension. Despite this progress, diagnostic challenges remain. Conventional screening with plasma aldosterone, renin, and the aldosterone-to-renin ratio suffers from intra-individual variability and interference by medications, diet, posture, amongst other factors. Even when PA is diagnosed, distinguishing lateralizing from nonlateralizing adrenal disease is difficult. The current gold-standard test, adrenal vein sampling, is invasive, technically demanding, confined to specialized centers, and often yields inconclusive results. Emerging biomarker research offers new opportunities. Novel steroidomic-based approaches, such as steroid profiling, show promise for both diagnosis and subtyping. Circulating and urinary proteomic and metabolomic signatures are beginning to reveal molecular fingerprints of PA and its subtypes, while transcriptomic studies of adrenal tissue, circulating cells, and extracellular vesicles, along with circulating microRNAs, provide insights into pathophysiology and candidate diagnostic markers. Markers of end-organ damage are also emerging as complementary indicators of disease burden and treatment response. This review synthesizes current molecular and clinical biomarker research in PA, with an emphasis on their diagnostic, subtyping, and prognostic potential. By integrating traditional hormone assays with advances in multidimensional biomarker discovery, we highlight possibilities that may transform the diagnosis and management of PA.<\/jats:p>","DOI":"10.1210\/endrev\/bnag016","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:03:46Z","timestamp":1779782626000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond aldosterone and renin: emerging biomarkers for diagnosing and subtyping primary aldosteronism"],"prefix":"10.1210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2015-6550","authenticated-orcid":false,"given":"Renata","family":"Libianto","sequence":"first","affiliation":[{"name":"Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L","family":"Uniacke","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]},{"name":"Department of Medicine, Monash University , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-2072","authenticated-orcid":false,"given":"Peter J","family":"Fuller","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-5375","authenticated-orcid":false,"given":"Morag J","family":"Young","sequence":"additional","affiliation":[{"name":"Cardiovascular Endocrinology Group, Baker Heart and Diabetes Institute , Melbourne, VIC 3004 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-4976","authenticated-orcid":false,"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]},{"name":"Department of Medicine, Monash University , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"9859","key":"2026062312011995500_bnag016-B1","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"2026062312011995500_bnag016-B2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa2415879","article-title":"Global effect of cardiovascular risk factors on lifetime estimates","volume":"393","author":"Magnussen","year":"2025","journal-title":"N Engl J Med"},{"issue":"19","key":"2026062312011995500_bnag016-B3","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2026062312011995500_bnag016-B4","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026062312011995500_bnag016-B5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2026062312011995500_bnag016-B6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026062312011995500_bnag016-B7","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society Clinical Practice Guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"38","key":"2026062312011995500_bnag016-B8","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"3","key":"2026062312011995500_bnag016-B9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.31128\/AJGP-07-19-4995","article-title":"Screening for primary aldosteronism: how to adjust existing antihypertensive medications to avoid diagnostic errors","volume":"49","author":"Gurgenci","year":"2020","journal-title":"Aust J Gen Pract"},{"issue":"1","key":"2026062312011995500_bnag016-B10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism","volume":"108","author":"Ng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026062312011995500_bnag016-B11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/ANNALS-24-03153","article-title":"Confirmatory testing for primary aldosteronism: a study of diagnostic test accuracy","volume":"178","author":"Leung","year":"2025","journal-title":"Ann Intern Med"},{"key":"2026062312011995500_bnag016-B12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/endrev\/bnaf007","article-title":"Subtyping of primary aldosteronism by adrenal venous sampling","volume":"46","author":"Rossi","year":"2025","journal-title":"Endocr Rev"},{"issue":"1","key":"2026062312011995500_bnag016-B13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1754-9485.13573","article-title":"The where, who and how of adrenal vein sampling in Australia and New Zealand","volume":"68","author":"Ng","year":"2024","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"7","key":"2026062312011995500_bnag016-B14","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/clinem\/dgae039","article-title":"Health care challenges in the management of primary aldosteronism in Southeast Asia","volume":"109","author":"Sukor","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026062312011995500_bnag016-B15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cen.14220","article-title":"Utility of adrenocorticotropic hormone in adrenal vein sampling despite the occurrence of discordant lateralization","volume":"93","author":"Chee","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026062312011995500_bnag016-B16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ejendo\/lvaf019","article-title":"Discordance between adrenal vein sampling and imaging: the role of unilateral cortisol excess","volume":"192","author":"Grundy","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026062312011995500_bnag016-B17","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026062312011995500_bnag016-B18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2967\/jnumed.123.266061","article-title":"Clinical value of (68)Ga-pentixafor PET\/CT in subtype diagnosis of primary aldosteronism patients with adrenal micronodules","volume":"65","author":"Ding","year":"2024","journal-title":"J Nucl Med"},{"key":"2026062312011995500_bnag016-B19","doi-asserted-by":"crossref","first-page":"112240","DOI":"10.1016\/j.ejrad.2025.112240","article-title":"Performance of pentixafor PET\/CT in identifying unilateral primary aldosteronism: a meta-analysis","volume":"190","author":"Gege","year":"2025","journal-title":"Eur J Radiol"},{"issue":"3","key":"2026062312011995500_bnag016-B20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2967\/jnumed.124.268425","article-title":"A phase I\/IIa clinical trial to evaluate safety and adrenal uptake of para-chloro-2-[(18)F]fluoroethyletomidate in healthy volunteers and patients with primary aldosteronism","volume":"66","author":"Gillett","year":"2025","journal-title":"J Nucl Med"},{"issue":"2","key":"2026062312011995500_bnag016-B21","doi-asserted-by":"crossref","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026062312011995500_bnag016-B22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"2","key":"2026062312011995500_bnag016-B23","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1210\/clinem\/dgad451","article-title":"Predicting bilateral subtypes of primary aldosteronism without adrenal vein sampling: a systematic review and meta-analysis","volume":"109","author":"Ng","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026062312011995500_bnag016-B24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/HJH.0000000000003132","article-title":"11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial","volume":"40","author":"Puar","year":"2022","journal-title":"J Hypertens"},{"issue":"1","key":"2026062312011995500_bnag016-B25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11307-024-01976-0","article-title":"(68)Ga-pentixafor PET\/CT is a supplementary method for primary aldosteronism subtyping compared with adrenal vein sampling","volume":"27","author":"Yi","year":"2025","journal-title":"Mol Imaging Biol"},{"issue":"3","key":"2026062312011995500_bnag016-B26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s12020-024-03865-6","article-title":"(68)Ga-pentixafor PET\/CT in the localization diagnosis of primary aldosteronism concurrent subclinical Cushing's syndrome: two case reports","volume":"85","author":"Wei","year":"2024","journal-title":"Endocrine"},{"issue":"1","key":"2026062312011995500_bnag016-B27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","article-title":"[(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial","volume":"29","author":"Wu","year":"2023","journal-title":"Nat Med"},{"key":"2026062312011995500_bnag016-B28","first-page":"100384","article-title":"(68)Ga-pentixafor PET\/CT in guiding surgical management of primary aldosteronism","volume":"39","author":"Zheng","year":"2025","journal-title":"J Clin Transl Endocrinol"},{"issue":"8","key":"2026062312011995500_bnag016-B29","doi-asserted-by":"crossref","first-page":"e2800","DOI":"10.1210\/clinem\/dgaf204","article-title":"Adrenal vein sampling in primary aldosteronism-is the gold standard losing its luster?","volume":"110","author":"Deinum","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062312011995500_bnag016-B30","author":"Bertolone"},{"key":"2026062312011995500_bnag016-B31","doi-asserted-by":"crossref","first-page":"104276","DOI":"10.1016\/j.ebiom.2022.104276","article-title":"Machine learning for classification of hypertension subtypes using multi-omics: a multi-centre, retrospective, data-driven study","volume":"84","author":"Reel","year":"2022","journal-title":"EBioMedicine"},{"issue":"21","key":"2026062312011995500_bnag016-B32","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.3390\/cancers13215582","article-title":"Transcriptomics, epigenetics, and metabolomics of primary aldosteronism","volume":"13","author":"Spyroglou","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2026062312011995500_bnag016-B33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/HYPERTENSIONAHA.111.188250","article-title":"Integrating genetics and genomics in primary aldosteronism","volume":"60","author":"Zennaro","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"2026062312011995500_bnag016-B34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol Rev"},{"key":"2026062312011995500_bnag016-B35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2026062312011995500_bnag016-B36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/er.2003-0001","article-title":"Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation","volume":"24","author":"Carey","year":"2003","journal-title":"Endocr Rev"},{"issue":"7","key":"2026062312011995500_bnag016-B37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/ijms17070797","article-title":"Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension","volume":"17","author":"Mu\u00f1oz-Durango","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2026062312011995500_bnag016-B38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"issue":"2","key":"2026062312011995500_bnag016-B39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semnephrol.2005.09.008","article-title":"The role of aldosterone in renal sodium transport","volume":"26","author":"Rozansky","year":"2006","journal-title":"Semin Nephrol"},{"issue":"5","key":"2026062312011995500_bnag016-B40","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.96.5.2514","article-title":"Epithelial sodium channel regulated by aldosterone-induced protein Sgk","volume":"96","author":"Chen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2026062312011995500_bnag016-B41","doi-asserted-by":"crossref","first-page":"F675","DOI":"10.1152\/ajprenal.2001.280.4.F675","article-title":"Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting system: possible role of SGK","volume":"280","author":"Loffing","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"2026062312011995500_bnag016-B42","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1172\/JCI7840","article-title":"Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney","volume":"104","author":"Masilamani","year":"1999","journal-title":"J Clin Invest"},{"issue":"8","key":"2026062312011995500_bnag016-B43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00424-022-02732-5","article-title":"Regulation of distal tubule sodium transport: mechanisms and roles in homeostasis and pathophysiology","volume":"474","author":"Pearce","year":"2022","journal-title":"Pflugers Arch"},{"issue":"1","key":"2026062312011995500_bnag016-B44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1152\/physrev.00011.2014","article-title":"Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited","volume":"95","author":"Rossier","year":"2015","journal-title":"Physiol Rev"},{"issue":"2","key":"2026062312011995500_bnag016-B45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","article-title":"Prerequisite for cardiac aldosterone action","volume":"92","author":"Lomb\u00e8s","year":"1995","journal-title":"Circulation"},{"issue":"6 Pt 1","key":"2026062312011995500_bnag016-B46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.HYP.26.6.971","article-title":"Biological determinants of aldosterone-induced cardiac fibrosis in rats","volume":"26","author":"Robert","year":"1995","journal-title":"Hypertension"},{"issue":"11","key":"2026062312011995500_bnag016-B47","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ Res"},{"issue":"7","key":"2026062312011995500_bnag016-B48","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/en.2011-2098","article-title":"Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis","volume":"153","author":"Bienvenu","year":"2012","journal-title":"Endocrinology"},{"issue":"9","key":"2026062312011995500_bnag016-B49","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"2026062312011995500_bnag016-B50","doi-asserted-by":"crossref","first-page":"e220249","DOI":"10.1530\/JOE-22-0249","article-title":"Mineralocorticoid receptor signalling in primary aldosteronism","volume":"259","author":"Yang","year":"2023","journal-title":"J Endocrinol"},{"issue":"1","key":"2026062312011995500_bnag016-B51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2026062312011995500_bnag016-B52","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2026062312011995500_bnag016-B53","doi-asserted-by":"crossref","first-page":"e1400","DOI":"10.1210\/clinem\/dgaa706","article-title":"Adrenal venous sampling-guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT)","volume":"106","author":"Ohno","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026062312011995500_bnag016-B54","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2213-8587(24)00378-4","article-title":"Adrenocortical carcinoma: a practical guide for clinicians","volume":"13","author":"Fassnacht","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026062312011995500_bnag016-B55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-031-85732-4_32","volume-title":"Surgical Oncology Clerkship: A Guide for Senior Medical Students","author":"Wang","year":"2025"},{"issue":"4","key":"2026062312011995500_bnag016-B56","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B57","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-21-0031","article-title":"Genetics in endocrinology: impact of race and sex on genetic causes of aldosterone-producing adenomas","volume":"185","author":"Nanba","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026062312011995500_bnag016-B58","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41588-023-01498-5","article-title":"Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism","volume":"55","author":"Rege","year":"2023","journal-title":"Nat Genet"},{"issue":"12","key":"2026062312011995500_bnag016-B59","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2026062312011995500_bnag016-B60","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension"},{"key":"2026062312011995500_bnag016-B61","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/HYPERTENSIONAHA.125.24909","article-title":"Somatic mutations in MCOLN3 are associated with aldosterone-producing adenomas","volume":"82","author":"van Rooyen","year":"2025","journal-title":"Hypertension"},{"issue":"6","key":"2026062312011995500_bnag016-B62","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41588-023-01403-0","article-title":"Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production","volume":"55","author":"Wu","year":"2023","journal-title":"Nat Genet"},{"issue":"9","key":"2026062312011995500_bnag016-B63","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41588-021-00906-y","article-title":"Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause","volume":"53","author":"Zhou","year":"2021","journal-title":"Nat Genet"},{"issue":"4","key":"2026062312011995500_bnag016-B64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrneph.2018.17","article-title":"CLCN2 chloride channel mutations in primary aldosteronism","volume":"14","author":"Allison","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"2026062312011995500_bnag016-B65","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"2026062312011995500_bnag016-B66","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"2026062312011995500_bnag016-B67","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/ijms19041124","article-title":"Comparative genomics and transcriptome profiling in primary aldosteronism","volume":"19","author":"Aristizabal Prada","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2026062312011995500_bnag016-B68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"2026062312011995500_bnag016-B69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"issue":"6018","key":"2026062312011995500_bnag016-B70","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"issue":"8","key":"2026062312011995500_bnag016-B71","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human Mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026062312011995500_bnag016-B72","doi-asserted-by":"crossref","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","article-title":"A Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III","volume":"98","author":"Monticone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062312011995500_bnag016-B73","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"eLife"},{"issue":"3","key":"2026062312011995500_bnag016-B74","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/nu13030875","article-title":"Unravelling the genetic basis of primary aldosteronism","volume":"13","author":"Mourtzi","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"2026062312011995500_bnag016-B75","doi-asserted-by":"crossref","first-page":"101375","DOI":"10.1016\/j.beem.2020.101375","article-title":"Old and new genes in primary aldosteronism","volume":"34","author":"Boulkroun","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2026062312011995500_bnag016-B76","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvae041","article-title":"Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline","volume":"190","author":"Mulatero","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026062312011995500_bnag016-B77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jama.1964.03070160037008","article-title":"Suppression of plasma renin activity in primary aldosteronism: distinguishing primary from secondary aldosteronism in hypertensive disease","volume":"190","author":"Conn","year":"1964","journal-title":"JAMA"},{"issue":"8","key":"2026062312011995500_bnag016-B78","doi-asserted-by":"crossref","first-page":"e1574","DOI":"10.1210\/clinem\/dgad752","article-title":"Prolonged hypokalemia and delayed diagnosis of primary aldosteronism: clinical course and risk factors","volume":"109","author":"Gupta","year":"2024","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"2026062312011995500_bnag016-B79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/HYPERTENSIONAHA.121.18284","article-title":"Feasibility of imaging-guided adrenalectomy in young patients with primary aldosteronism","volume":"79","author":"Rossi","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"2026062312011995500_bnag016-B80","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1210\/jc.2017-01774","article-title":"Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism","volume":"103","author":"Umakoshi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026062312011995500_bnag016-B81","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3949\/ccjm.88a.20166","article-title":"Our evolving understanding of primary aldosteronism","volume":"88","author":"Mehdi","year":"2021","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"2026062312011995500_bnag016-B82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"issue":"11","key":"2026062312011995500_bnag016-B83","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2026062312011995500_bnag016-B84","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/HYPERTENSIONAHA.123.21965","article-title":"Diagnostic delay and disease burden in primary aldosteronism: an international patient survey","volume":"81","author":"Ananda","year":"2024","journal-title":"Hypertension"},{"key":"2026062312011995500_bnag016-B85","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.autneu.2018.04.004","article-title":"Evaluation of postural tachycardia syndrome (POTS)","volume":"215","author":"Goodman","year":"2018","journal-title":"Auton Neurosci"},{"issue":"1","key":"2026062312011995500_bnag016-B86","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13643-023-02250-0","article-title":"A systematic review and meta-analysis of long COVID symptoms","volume":"12","author":"Natarajan","year":"2023","journal-title":"Syst Rev"},{"key":"2026062312011995500_bnag016-B87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fped.2017.00121","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome diagnosis and management in young people: a primer","volume":"5","author":"Rowe","year":"2017","journal-title":"Front Pediatr"},{"issue":"12","key":"2026062312011995500_bnag016-B88","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1055\/s-0043-121706","article-title":"Health-related quality of life and mental health in primary aldosteronism: a systematic review","volume":"49","author":"Velema","year":"2017","journal-title":"Horm Metab Res"},{"issue":"3","key":"2026062312011995500_bnag016-B89","doi-asserted-by":"crossref","first-page":"e13419","DOI":"10.1111\/eci.13419","article-title":"Quality of life in primary aldosteronism: a prospective observational study","volume":"51","author":"Buffolo","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 1","key":"2026062312011995500_bnag016-B90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12893-018-0432-1","article-title":"Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism","volume":"18","author":"Citton","year":"2019","journal-title":"BMC Surg"},{"issue":"8","key":"2026062312011995500_bnag016-B91","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1530\/EC-21-0125","article-title":"Improvement in quality of life and psychological symptoms after treatment for primary aldosteronism: Asian Cohort Study","volume":"10","author":"Tan","year":"2021","journal-title":"Endocr Connect"},{"issue":"4","key":"2026062312011995500_bnag016-B92","doi-asserted-by":"crossref","first-page":"bvab020","DOI":"10.1210\/jendso\/bvab020","article-title":"Quality of life of primary aldosteronism patients by mineralocorticoid receptor antagonists","volume":"5","author":"Yoshida","year":"2021","journal-title":"J Endocr Soc"},{"issue":"1","key":"2026062312011995500_bnag016-B93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eprac.2023.10.003","article-title":"A prospective observational study of factors affecting the change in quality of life in patients with primary aldosteronism after treatment","volume":"30","author":"Yu","year":"2024","journal-title":"Endocr Pract"},{"issue":"6","key":"2026062312011995500_bnag016-B94","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/HYPERTENSIONAHA.120.16909","article-title":"Time-dependent risk of atrial fibrillation in patients with primary aldosteronism after medical or surgical treatment initiation","volume":"77","author":"Kim","year":"2021","journal-title":"Hypertension"},{"issue":"8","key":"2026062312011995500_bnag016-B95","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2026062312011995500_bnag016-B96","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026062312011995500_bnag016-B97","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","article-title":"Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan","volume":"71","author":"Ohno","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"2026062312011995500_bnag016-B98","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"2","key":"2026062312011995500_bnag016-B99","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"issue":"6 Pt 1","key":"2026062312011995500_bnag016-B100","doi-asserted-by":"crossref","first-page":"101762","DOI":"10.1016\/j.jacadv.2025.101762","article-title":"Aldosterone-related cardiovascular disease and benefits of mineralocorticoid receptor antagonists in clinical practice","volume":"4","author":"Alfarano","year":"2025","journal-title":"JACC Adv"},{"issue":"6","key":"2026062312011995500_bnag016-B101","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"2026062312011995500_bnag016-B102","doi-asserted-by":"crossref","first-page":"798364","DOI":"10.3389\/fcvm.2021.798364","article-title":"Cerebro-cardiovascular risk, target organ damage, and treatment outcomes in primary aldosteronism","volume":"8","author":"Lin","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"2026062312011995500_bnag016-B103","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/EBC20210006","article-title":"Mineralocorticoid receptor actions in cardiovascular development and disease","volume":"65","author":"Young","year":"2021","journal-title":"Essays Biochem"},{"issue":"5","key":"2026062312011995500_bnag016-B104","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026062312011995500_bnag016-B105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm Metab Res"},{"issue":"5","key":"2026062312011995500_bnag016-B106","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","article-title":"Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans","volume":"75","author":"Adler","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B107","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12020-020-02576-y","article-title":"Insulin sensitivity and pancreatic \u03b2-cell function in patients with primary aldosteronism","volume":"72","author":"Grewal","year":"2021","journal-title":"Endocrine"},{"issue":"4","key":"2026062312011995500_bnag016-B108","doi-asserted-by":"crossref","first-page":"dgz293","DOI":"10.1210\/clinem\/dgz293","article-title":"Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes and hypertension","volume":"105","author":"Hu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026062312011995500_bnag016-B109","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026062312011995500_bnag016-B110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"6","key":"2026062312011995500_bnag016-B111","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/a-1133-7255","article-title":"Primary aldosteronism and obstructive sleep apnea: casual association or pathophysiological link?","volume":"52","author":"Pecori","year":"2020","journal-title":"Horm Metab Res"},{"issue":"9","key":"2026062312011995500_bnag016-B112","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/jhh.2017.28","article-title":"Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea","volume":"31","author":"Wolley","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"4","key":"2026062312011995500_bnag016-B113","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2016-3206","article-title":"Primary aldosteronism as a risk factor for vertebral fracture","volume":"102","author":"Notsu","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"issue":"10","key":"2026062312011995500_bnag016-B114","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026062312011995500_bnag016-B115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-17-0417","article-title":"Primary aldosteronism as a cause of secondary osteoporosis","volume":"177","author":"Salcuni","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026062312011995500_bnag016-B116","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3033","article-title":"Risk of fracture in primary aldosteronism: a population-based Cohort Study","volume":"32","author":"Wu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2026062312011995500_bnag016-B117","doi-asserted-by":"crossref","first-page":"836529","DOI":"10.1155\/2014\/836529","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","author":"Petramala","year":"2014","journal-title":"Int J Endocrinol"},{"key":"2026062312011995500_bnag016-B118","doi-asserted-by":"crossref","first-page":"e3694","DOI":"10.1210\/clinem\/dgaf151","article-title":"Changes in PTH across the spectrum of renin-independent aldosteronism","volume":"110","author":"Ooi","year":"2025","journal-title":"J Clin Endocrinol Metabol"},{"issue":"4","key":"2026062312011995500_bnag016-B119","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/a-1027-6472","article-title":"Primary and secondary hyperparathyroidism in patients with primary aldosteronism\u2014findings from the German Conn's registry","volume":"128","author":"Asbach","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2026062312011995500_bnag016-B120","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2012","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"2026062312011995500_bnag016-B121","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"issue":"8","key":"2026062312011995500_bnag016-B122","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"issue":"16","key":"2026062312011995500_bnag016-B123","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2026062312011995500_bnag016-B124","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"issue":"9","key":"2026062312011995500_bnag016-B125","doi-asserted-by":"crossref","first-page":"e2833","DOI":"10.1210\/clinem\/dgaf290","article-title":"A systematic review supporting the Endocrine Society clinical practice guideline on management of primary aldosteronism","volume":"110","author":"Farah","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026062312011995500_bnag016-B126","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/cen.14478","article-title":"Cost-effectiveness analysis of screening for primary aldosteronism in China","volume":"95","author":"Li","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2026062312011995500_bnag016-B127","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/HJH.0000000000003513","article-title":"Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis","volume":"41","author":"Woode","year":"2023","journal-title":"J Hypertens"},{"issue":"3","key":"2026062312011995500_bnag016-B128","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"issue":"8","key":"2026062312011995500_bnag016-B129","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1515\/cclm-2022-1190","article-title":"Standard -20 \u00b0C freezer storage protocols may cause substantial plasma renin cryoactivation","volume":"61","author":"Bonnitcha","year":"2023","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"2026062312011995500_bnag016-B130","doi-asserted-by":"crossref","first-page":"e1472","DOI":"10.1210\/clinem\/dgae057","article-title":"The clinical impact of sample storage at -20\u2005\u00b0C on renin reference intervals and aldosterone-renin ratio calculations","volume":"109","author":"\u00d6zcan","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026062312011995500_bnag016-B131","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1515\/cclm-2022-0375","article-title":"Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours","volume":"60","author":"Hepburn","year":"2022","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"2026062312011995500_bnag016-B132","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026062312011995500_bnag016-B133","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1515\/cclm-2024-1468","article-title":"Investigation of the possible cause of over-estimation of human aldosterone in plasma, using a unique, non-synthetic human aldosterone-free matrix","volume":"63","author":"Stoner","year":"2025","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"2026062312011995500_bnag016-B134","doi-asserted-by":"crossref","first-page":"bvac049","DOI":"10.1210\/jendso\/bvac049","article-title":"Recalibrating interpretations of aldosterone assays across the physiologic range: immunoassay and liquid chromatography-tandem mass spectrometry measurements under multiple controlled conditions","volume":"6","author":"Brown","year":"2022","journal-title":"J Endocr Soc"},{"key":"2026062312011995500_bnag016-B135","doi-asserted-by":"crossref","first-page":"120604","DOI":"10.1016\/j.cca.2025.120604","article-title":"Liquid chromatography-tandem mass spectrometry-based recalibration reduces inter-platform variability in aldosterone detection across chemiluminescence immunoassay platforms","volume":"579","author":"Zhang","year":"2026","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2026062312011995500_bnag016-B136","doi-asserted-by":"crossref","first-page":"lvac002","DOI":"10.1093\/ejendo\/lvac002","article-title":"International multicenter survey on screening and confirmatory testing in primary aldosteronism","volume":"188","author":"Naruse","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026062312011995500_bnag016-B137","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-022-03084-x","article-title":"Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care","volume":"77","author":"Ariens","year":"2022","journal-title":"Endocrine"},{"key":"2026062312011995500_bnag016-B138","doi-asserted-by":"crossref","first-page":"8647026","DOI":"10.1155\/2018\/8647026","article-title":"Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening","volume":"2018","author":"Ma","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"5","key":"2026062312011995500_bnag016-B139","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026062312011995500_bnag016-B140","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.jfma.2023.04.019","article-title":"Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)","volume":"123 Suppl 2","author":"Lin","year":"2024","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"2026062312011995500_bnag016-B141","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"issue":"7","key":"2026062312011995500_bnag016-B142","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41371-020-0336-2","article-title":"Primary aldosteronism is a public health issue: challenges and opportunities","volume":"34","author":"Libianto","year":"2020","journal-title":"J Hum Hypertens"},{"key":"2026062312011995500_bnag016-B143","doi-asserted-by":"crossref","first-page":"684111","DOI":"10.3389\/fphar.2021.684111","article-title":"The effect of antihypertensive medications on testing for primary aldosteronism","volume":"12","author":"J\u0119drusik","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"2026062312011995500_bnag016-B144","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","article-title":"Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism","volume":"32","author":"Jansen","year":"2014","journal-title":"J Hypertens"},{"issue":"6","key":"2026062312011995500_bnag016-B145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B146","first-page":"09","article-title":"Progestogen-only pill associates with false-positive aldosterone\/renin ratio screening test","volume":"27","author":"Birkinshaw","year":"2020","journal-title":"Br J Cardiol"},{"issue":"5","key":"2026062312011995500_bnag016-B147","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.116.08793","article-title":"Safety of temporary discontinuation of antihypertensive medication in patients with difficult-to-control hypertension","volume":"69","author":"Beeftink","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B148","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","article-title":"Commentary on the Endocrine Society Practice Guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism","volume":"12","author":"Fischer","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"2026062312011995500_bnag016-B149","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.116.07214","article-title":"Suppression of aldosterone secretion after recumbent saline infusion does not exclude lateralized primary aldosteronism","volume":"68","author":"Cornu","year":"2016","journal-title":"Hypertension"},{"issue":"9","key":"2026062312011995500_bnag016-B150","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1210\/clinem\/dgae145","article-title":"The spectrum of dysregulated aldosterone production: an international human physiology study","volume":"109","author":"Parksook","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026062312011995500_bnag016-B151","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"issue":"2","key":"2026062312011995500_bnag016-B152","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/clinem\/dgac654","article-title":"Exclusion tests in Unilateral Primary Aldosteronism (ExcluPA) study","volume":"108","author":"Zhu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026062312011995500_bnag016-B153","doi-asserted-by":"crossref","first-page":"L36","DOI":"10.1093\/ejendo\/lvaf232","article-title":"The not-so-shortcomings of seated saline suppression testing in primary aldosteronism","volume":"193","author":"Stowasser","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"16","key":"2026062312011995500_bnag016-B154","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMcp2031112","article-title":"Adrenal incidentaloma","volume":"384","author":"Kebebew","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"2026062312011995500_bnag016-B155","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026062312011995500_bnag016-B156","first-page":"1066","article-title":"Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism","volume":"86","author":"Magill","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026062312011995500_bnag016-B157","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B158","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2265.2008.03450.x","article-title":"What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?","volume":"70","author":"Young","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026062312011995500_bnag016-B159","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cen.13110","article-title":"Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?","volume":"85","author":"Wolley","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026062312011995500_bnag016-B160","doi-asserted-by":"crossref","first-page":"dgz017","DOI":"10.1210\/clinem\/dgz017","article-title":"Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization","volume":"105","author":"Rossitto","year":"2020","journal-title":"J Clin Endocrinol Metabol"},{"issue":"3","key":"2026062312011995500_bnag016-B161","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1148\/radiol.212627","article-title":"Impact of intraprocedural sedation on adrenal vein sampling without corticotropin stimulation","volume":"304","author":"Yang","year":"2022","journal-title":"Radiology"},{"issue":"1","key":"2026062312011995500_bnag016-B162","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.15139","article-title":"Adrenal vein sampling for primary aldosteronism: recommendations from the Australian and New Zealand Working Group","volume":"102","author":"Yang","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026062312011995500_bnag016-B163","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fendo.2016.00072","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026062312011995500_bnag016-B164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.254.1","article-title":"Pathology of aldosterone biosynthesis and its action","volume":"254","author":"Gao","year":"2021","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"2026062312011995500_bnag016-B165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.124.24153","article-title":"Characterizing the origins of primary aldosteronism","volume":"82","author":"Brown","year":"2025","journal-title":"Hypertension"},{"issue":"6","key":"2026062312011995500_bnag016-B166","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYPERTENSIONAHA.118.11369","article-title":"Visualizing adrenal steroids in primary aldosteronism","volume":"72","author":"Gomez-Sanchez","year":"2018","journal-title":"Hypertension"},{"issue":"9","key":"2026062312011995500_bnag016-B167","doi-asserted-by":"crossref","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026062312011995500_bnag016-B168","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","article-title":"Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping","volume":"75","author":"Turcu","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B169","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1210\/jcem-64-1-140","article-title":"Steroidogenesis in the human fetal adrenal: a role for cholesterol synthesized de novo","volume":"64","author":"Mason","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026062312011995500_bnag016-B170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/edrv-9-3-295","article-title":"Molecular biology of steroid hormone synthesis","volume":"9","author":"Miller","year":"1988","journal-title":"Endocr Rev"},{"issue":"35","key":"2026062312011995500_bnag016-B171","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1016\/S0021-9258(19)30030-4","article-title":"Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta)","volume":"264","author":"Mornet","year":"1989","journal-title":"J Biol Chem"},{"issue":"2","key":"2026062312011995500_bnag016-B172","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol Rev"},{"issue":"9","key":"2026062312011995500_bnag016-B173","first-page":"4326","article-title":"Effects of 18-hydroxylated steroids on corticosteroid production by human aldosterone synthase and 11beta-hydroxylase","volume":"86","author":"Fisher","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026062312011995500_bnag016-B174","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.HYP.38.3.688","article-title":"Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives","volume":"38","author":"Mosso","year":"2001","journal-title":"Hypertension"},{"issue":"3","key":"2026062312011995500_bnag016-B175","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2011-2384","article-title":"18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes","volume":"97","author":"Mulatero","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026062312011995500_bnag016-B176","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/jcem-49-1-87","article-title":"The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism","volume":"49","author":"Biglieri","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"issue":"9-10","key":"2026062312011995500_bnag016-B177","first-page":"1771","article-title":"Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension","volume":"4","author":"Ulick","year":"1982","journal-title":"Clin Exp Hypertens A"},{"issue":"5","key":"2026062312011995500_bnag016-B178","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0021-9258(18)34909-3","article-title":"Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism","volume":"257","author":"Chu","year":"1982","journal-title":"J Biol Chem"},{"issue":"9","key":"2026062312011995500_bnag016-B179","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1016\/S0021-9258(20)81918-8","article-title":"Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue","volume":"258","author":"Ulick","year":"1983","journal-title":"J Biol Chem"},{"issue":"6357","key":"2026062312011995500_bnag016-B180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"issue":"6","key":"2026062312011995500_bnag016-B181","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/er.2018-00262","article-title":"Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism","volume":"40","author":"Storbeck","year":"2019","journal-title":"Endocr Rev"},{"issue":"Pt 3","key":"2026062312011995500_bnag016-B182","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/000456328902600303","article-title":"18-Hydroxycorticosterone as a marker for primary hyperaldosteronism","volume":"26","author":"Lapworth","year":"1989","journal-title":"Ann Clin Biochem"},{"issue":"12","key":"2026062312011995500_bnag016-B183","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1515\/cclm-2022-0470","article-title":"Integration of artificial intelligence and plasma steroidomics with laboratory information management systems: application to primary aldosteronism","volume":"60","author":"Constantinescu","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2026062312011995500_bnag016-B184","doi-asserted-by":"crossref","first-page":"106445","DOI":"10.1016\/j.jsbmb.2023.106445","article-title":"Urine steroid metabolomics as a diagnostic tool in primary aldosteronism","volume":"237","author":"Prete","year":"2024","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"2026062312011995500_bnag016-B185","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.118.12064","article-title":"18-Oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status","volume":"73","author":"Tezuka","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B186","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/gs.2019.10.22","article-title":"Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas","volume":"9","author":"Rege","year":"2020","journal-title":"Gland Surg"},{"issue":"6-7","key":"2026062312011995500_bnag016-B187","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1440-1681.1996.tb02789.x","article-title":"Production of 18-oxo-cortisol in subtypes of primary aldosteronism","volume":"23","author":"Stowasser","year":"1996","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"2026062312011995500_bnag016-B188","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension"},{"issue":"5","key":"2026062312011995500_bnag016-B189","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"issue":"2","key":"2026062312011995500_bnag016-B190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/jcem-29-2-239","article-title":"Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma","volume":"29","author":"Slaton PE","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062312011995500_bnag016-B191","doi-asserted-by":"crossref","first-page":"1096441","DOI":"10.3389\/fendo.2023.1096441","article-title":"Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism","volume":"14","author":"Bertolone","year":"2023","journal-title":"Front Endocrinol"},{"issue":"6","key":"2026062312011995500_bnag016-B192","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ejendo\/lvae148","article-title":"Targeted multiplex proteomics for the development and validation of biomarkers in primary aldosteronism subtyping","volume":"191","author":"Zhou","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026062312011995500_bnag016-B193","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12020-025-04302-y","article-title":"Searching for peripheral proteomic markers of primary aldosteronism","volume":"89","author":"Makhnov","year":"2025","journal-title":"Endocrine"},{"key":"2026062312011995500_bnag016-B194","doi-asserted-by":"crossref","first-page":"1548344","DOI":"10.3389\/fendo.2025.1548344","article-title":"Advances in the biochemical diagnostics of primary aldosteronism: from immunoassays to steroidomics and proteomics","volume":"16","author":"Szatko","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026062312011995500_bnag016-B195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.12786","article-title":"Angs (angiotensins) of the alternative renin-angiotensin system predict outcome in patients with heart failure and preserved ejection fraction","volume":"74","author":"Binder","year":"2019","journal-title":"Hypertension"},{"issue":"3","key":"2026062312011995500_bnag016-B196","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/clinchem\/hvaa001","article-title":"Measurement of equilibrium Angiotensin II in the diagnosis of primary aldosteronism","volume":"66","author":"Guo","year":"2020","journal-title":"Clin Chem"},{"issue":"4","key":"2026062312011995500_bnag016-B197","doi-asserted-by":"crossref","first-page":"1470320316669880","DOI":"10.1177\/1470320316669880","article-title":"Quantification of systemic renin-angiotensin system peptides of hypertensive black and white African men established from the RAS-Fingerprint\u00ae","volume":"17","author":"van Rooyen","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"5","key":"2026062312011995500_bnag016-B198","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/diagnostics12051124","article-title":"Poor performance of angiotensin II enzyme-linked immuno-sorbent assays in mostly hypertensive cohort routinely screened for primary aldosteronism","volume":"12","author":"\u0141ebek-Szata\u0144ska","year":"2022","journal-title":"Diagnostics"},{"issue":"1","key":"2026062312011995500_bnag016-B199","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/HYPERTENSIONAHA.119.13772","article-title":"Renin-angiotensin-aldosterone system triple-A analysis for the screening of primary aldosteronism","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"issue":"9","key":"2026062312011995500_bnag016-B200","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1515\/cclm-2024-1312","article-title":"Screening primary aldosteronism by plasma aldosterone-to-angiotensin II ratio","volume":"63","author":"Lo","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"2026062312011995500_bnag016-B201","doi-asserted-by":"crossref","first-page":"9640103","DOI":"10.1155\/2020\/9640103","article-title":"Adrenal (pro)renin receptor expression and serum soluble (pro)renin receptor concentration in primary aldosteronism","volume":"2020","author":"Watanabe","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"6","key":"2026062312011995500_bnag016-B202","doi-asserted-by":"crossref","first-page":"C1439","DOI":"10.1152\/ajpcell.00349.2023","article-title":"Exploring the role of urinary extracellular vesicles in kidney physiology, aging, and disease progression","volume":"325","author":"Grange","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"2026062312011995500_bnag016-B203","doi-asserted-by":"crossref","first-page":"bqab032","DOI":"10.1210\/endocr\/bqab032","article-title":"Proteomic profile of urinary extracellular vesicles identifies AGP1 as a potential biomarker of primary aldosteronism","volume":"162","author":"Barros","year":"2021","journal-title":"Endocrinology"},{"issue":"15","key":"2026062312011995500_bnag016-B204","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.3390\/ijms25158004","article-title":"Urinary extracellular vesicles as a readily available biomarker source: a simplified stratification method","volume":"25","author":"Filipovi\u0107","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026062312011995500_bnag016-B205","doi-asserted-by":"crossref","first-page":"1155011","DOI":"10.3389\/fendo.2023.1155011","article-title":"Urinary extracellular vesicles carry valuable hints through mRNA for the understanding of endocrine hypertension","volume":"14","author":"Friso","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026062312011995500_bnag016-B206","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.118.11733","article-title":"Proteomic landscape of aldosterone-producing adenoma","volume":"73","author":"Swierczynska","year":"2019","journal-title":"Hypertension"},{"issue":"5","key":"2026062312011995500_bnag016-B207","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/HYPERTENSIONAHA.122.20515","article-title":"Phosphoproteomics reveals the Wolframin-calcium axis as an important pathogenic signaling node in primary aldosteronism","volume":"80","author":"Ma","year":"2023","journal-title":"Hypertension"},{"issue":"6","key":"2026062312011995500_bnag016-B208","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.numecd.2021.01.008","article-title":"The evolving landscape of untargeted metabolomics","volume":"31","author":"Di Minno","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"6","key":"2026062312011995500_bnag016-B209","doi-asserted-by":"crossref","first-page":"e5855","DOI":"10.1002\/bmc.5855","article-title":"Untargeted metabolomics reveals potential plasma biomarkers for diagnosis of primary aldosteronism using liquid chromatography-mass spectrometry","volume":"38","author":"Song","year":"2024","journal-title":"Biomed Chromatogr"},{"issue":"4","key":"2026062312011995500_bnag016-B210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/clinem\/dgaa954","article-title":"Targeted metabolomics as a tool in discriminating endocrine from primary hypertension","volume":"106","author":"Erlic","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026062312011995500_bnag016-B211","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.13891","article-title":"Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker","volume":"90","author":"Berends","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026062312011995500_bnag016-B212","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1210\/clinem\/dgae204","article-title":"Enhanced chronic inflammation and increased branched-chain amino acids in adrenal disorders: a cross-sectional study","volume":"110","author":"Kittithaworn","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026062312011995500_bnag016-B213","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/HJH.0000000000000168","article-title":"Metabolomics in hypertension","volume":"32","author":"Nikolic","year":"2014","journal-title":"J Hypertens"},{"issue":"2","key":"2026062312011995500_bnag016-B214","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mas.21455","article-title":"Mass spectrometric based approaches in urine metabolomics and biomarker discovery","volume":"36","author":"Khamis","year":"2017","journal-title":"Mass Spectrom Rev"},{"issue":"4","key":"2026062312011995500_bnag016-B215","doi-asserted-by":"crossref","first-page":"e1800049","DOI":"10.1002\/prca.201800049","article-title":"Urinary metabolic signature of primary aldosteronism: gender and subtype-specific alterations","volume":"13","author":"Lana","year":"2019","journal-title":"Proteomics Clin Appl"},{"issue":"1-2","key":"2026062312011995500_bnag016-B216","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2014.05.002","article-title":"Adrenal CYP11B1\/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies","volume":"392","author":"Nakamura","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"2026062312011995500_bnag016-B217","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/HYPERTENSIONAHA.123.20921","article-title":"Primary aldosteronism: spatial multiomics mapping of genotype-dependent heterogeneity and tumor expansion of aldosterone-producing adenomas","volume":"80","author":"Gong","year":"2023","journal-title":"Hypertension"},{"issue":"4","key":"2026062312011995500_bnag016-B218","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/EJE-10-1085","article-title":"Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands","volume":"164","author":"Wang","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026062312011995500_bnag016-B219","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1210\/jc.2005-1309","article-title":"Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis","volume":"90","author":"Assi\u00e9","year":"2005","journal-title":"J Clin Endocrinol Metabol"},{"issue":"9","key":"2026062312011995500_bnag016-B220","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1210\/jc.2005-0836","article-title":"Expression profiles for steroidogenic enzymes in adrenocortical disease","volume":"90","author":"Bassett","year":"2005","journal-title":"J Clin Endocrinol Metabol"},{"issue":"4","key":"2026062312011995500_bnag016-B221","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2026062312011995500_bnag016-B222","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"2026062312011995500_bnag016-B223","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2016.10.002","article-title":"CACNA1H mutations are associated with different forms of primary aldosteronism","volume":"13","author":"Daniil","year":"2016","journal-title":"EBioMedicine"},{"issue":"4","key":"2026062312011995500_bnag016-B224","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.111.188532","article-title":"Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis","volume":"59","author":"Williams","year":"2012","journal-title":"Hypertension"},{"issue":"5","key":"2026062312011995500_bnag016-B225","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metabol"},{"issue":"4","key":"2026062312011995500_bnag016-B226","doi-asserted-by":"crossref","first-page":"E674","DOI":"10.1210\/jc.2013-2900","article-title":"Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism","volume":"99","author":"Lenzini","year":"2014","journal-title":"J Clin Endocrinol Metabol"},{"issue":"5","key":"2026062312011995500_bnag016-B227","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.119.13287","article-title":"ANO4 (anoctamin 4) is a novel marker of zona glomerulosa that regulates stimulated aldosterone secretion","volume":"74","author":"Maniero","year":"2019","journal-title":"Hypertension"},{"key":"2026062312011995500_bnag016-B228","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mce.2017.08.019","article-title":"Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma","volume":"461","author":"Itcho","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"2026062312011995500_bnag016-B229","doi-asserted-by":"crossref","first-page":"644382","DOI":"10.3389\/fendo.2021.644382","article-title":"Aldosterone-regulating receptors and aldosterone-driver somatic mutations","volume":"12","author":"Lim","year":"2021","journal-title":"Front Endocrinol"},{"issue":"3","key":"2026062312011995500_bnag016-B230","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/jc.2005-1298","article-title":"Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas","volume":"91","author":"Saner-Amigh","year":"2006","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"2026062312011995500_bnag016-B231","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1677\/JOE-07-0037","article-title":"G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism","volume":"195","author":"Ye","year":"2007","journal-title":"J Endocrinol"},{"issue":"9","key":"2026062312011995500_bnag016-B232","first-page":"10009","article-title":"Transcriptome analysis of primary aldosteronism in adrenal glands and controls","volume":"10","author":"Chu","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2026062312011995500_bnag016-B233","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1038\/s41598-019-41525-2","article-title":"RNA sequencing provides novel insights into the transcriptome of aldosterone producing adenomas","volume":"9","author":"Backman","year":"2019","journal-title":"Sci Rep"},{"key":"2026062312011995500_bnag016-B234","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303361250250119035029","article-title":"Integrative analysis of metabolomic and transcriptomic data reveals metabolic signatures and major metabolic pathways in primary aldosteronism","author":"Lai","journal-title":"Endocr Metab Immune Disorders-Drug Targets"},{"key":"2026062312011995500_bnag016-B235","doi-asserted-by":"crossref","first-page":"1511096","DOI":"10.3389\/fendo.2025.1511096","article-title":"Serum microRNAs as peripheral markers of primary aldosteronism","volume":"16","author":"Makhnov","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2026062312011995500_bnag016-B236","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ejendo\/lvaf052","article-title":"Identification of hypertension subtypes using microRNA profiles and machine learning","volume":"192","author":"Reel","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"40","key":"2026062312011995500_bnag016-B237","doi-asserted-by":"crossref","first-page":"14518","DOI":"10.1073\/pnas.1215767111","article-title":"MicroRNA-223 coordinates cholesterol homeostasis","volume":"111","author":"Vickers","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2026062312011995500_bnag016-B238","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/genes13071225","article-title":"Identification of antitumor miR-30e-5p controlled genes; diagnostic and prognostic biomarkers for head and neck squamous cell carcinoma","volume":"13","author":"Minemura","year":"2022","journal-title":"Genes (Basel)"},{"issue":"1","key":"2026062312011995500_bnag016-B239","doi-asserted-by":"crossref","first-page":"2315651","DOI":"10.1080\/15384047.2024.2315651","article-title":"miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2","volume":"25","author":"Xia","year":"2024","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"2026062312011995500_bnag016-B240","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1210\/jc.2018-00059","article-title":"Clinical characteristics and postoperative outcomes of primary aldosteronism in the elderly","volume":"103","author":"Takeda","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026062312011995500_bnag016-B241","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.3390\/ijms24065782","article-title":"Molecular and epigenetic control of aldosterone synthase, CYP11B2 and 11-hydroxylase, CYP11B1","volume":"24","author":"Takeda","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2026062312011995500_bnag016-B242","doi-asserted-by":"crossref","first-page":"e008281","DOI":"10.1161\/JAHA.117.008281","article-title":"Epigenetic regulation of aldosterone synthase gene by sodium and angiotensin II","volume":"7","author":"Takeda","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2026062312011995500_bnag016-B243","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13148-022-01347-y","article-title":"Whole blood methylome-derived features to discriminate endocrine hypertension","volume":"14","author":"Armignacco","year":"2022","journal-title":"Clin Epigenet"},{"issue":"2","key":"2026062312011995500_bnag016-B244","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40292-015-0084-5","article-title":"Issues in the diagnosis and treatment of primary aldosteronism","volume":"23","author":"Burrello","year":"2016","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"6","key":"2026062312011995500_bnag016-B245","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00423-013-1093-2","article-title":"Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway","volume":"398","author":"Arnesen","year":"2013","journal-title":"Langenbecks Arch Surg"},{"issue":"9","key":"2026062312011995500_bnag016-B246","doi-asserted-by":"crossref","first-page":"e2918","DOI":"10.1210\/clinem\/dgaf007","article-title":"KCNJ5 somatic mutations are associated with better long-term outcomes in patients with unilateral primary aldosteronism","volume":"110","author":"Chan","year":"2025","journal-title":"J Clin Endocrinol Metabol"},{"issue":"3","key":"2026062312011995500_bnag016-B247","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-21-0338","article-title":"Somatic mutations in adrenals from patients with primary aldosteronism not cured after adrenalectomy suggest common pathogenic mechanisms between unilateral and bilateral disease","volume":"185","author":"Hacini","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026062312011995500_bnag016-B248","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ans.12470","article-title":"Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism","volume":"85","author":"Ip","year":"2015","journal-title":"ANZ J Surg"},{"issue":"10","key":"2026062312011995500_bnag016-B249","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/HYPERTENSIONAHA.125.24999","article-title":"Cosyntropin-stimulated aldosterone reserve of the nondominant adrenal predicts surgical outcomes in primary aldosteronism","volume":"82","author":"Vibhatavata","year":"2025","journal-title":"Hypertension"},{"issue":"2","key":"2026062312011995500_bnag016-B250","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1210\/jcem-65-2-310","article-title":"Urinary 18-hydroxycortisol and its relationship to the excretion of other adrenal steroids","volume":"65","author":"Gomez-Sanchez","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026062312011995500_bnag016-B251","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/jcem-67-2-322","article-title":"Effect of chronic adrenocorticotropin stimulation on the excretion of 18-hydroxycortisol and 18-oxocortisol","volume":"67","author":"Gomez-Sanchez","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026062312011995500_bnag016-B252","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"issue":"6-7","key":"2026062312011995500_bnag016-B253","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1440-1681.1995.tb02038.x","article-title":"Hybrid gene or hybrid steroids in the detection and screening for familial hyperaldosteronism type I","volume":"22","author":"Stowasser","year":"1995","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2026062312011995500_bnag016-B254","doi-asserted-by":"crossref","first-page":"834409","DOI":"10.3389\/fendo.2022.834409","article-title":"The role of urinary extracellular vesicles sodium chloride cotransporter in subtyping primary aldosteronism","volume":"13","author":"Kong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2026062312011995500_bnag016-B255","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1039\/C3MB70538B","article-title":"Urinary protease inhibitor serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma","volume":"10","author":"Olivieri","year":"2014","journal-title":"Mol Biosyst"},{"issue":"8","key":"2026062312011995500_bnag016-B256","doi-asserted-by":"crossref","first-page":"e1582","DOI":"10.1210\/clinem\/dgad747","article-title":"Correlation of histopathologic subtypes of primary aldosteronism with clinical phenotypes and postsurgical outcomes","volume":"109","author":"Ahn","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026062312011995500_bnag016-B257","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11906-019-0985-0","article-title":"Steroid profiling and immunohistochemistry for subtyping and outcome prediction in primary aldosteronism\u2014a review","volume":"21","author":"Holler","year":"2019","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"2026062312011995500_bnag016-B258","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.119.12944","article-title":"Characterization and gene expression analysis of serum-derived extracellular vesicles in primary aldosteronism","volume":"74","author":"Burrello","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B259","doi-asserted-by":"crossref","first-page":"bqab240","DOI":"10.1210\/endocr\/bqab240","article-title":"Primary aldosteronism, aldosterone, and extracellular vesicles","volume":"163","author":"Carvajal","year":"2022","journal-title":"Endocrinology"},{"issue":"1","key":"2026062312011995500_bnag016-B260","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1038\/s41467-022-32896-8","article-title":"Identification of risk loci for primary aldosteronism in genome-wide association studies","volume":"13","author":"Le Floch","year":"2022","journal-title":"Nat Commun"},{"issue":"14","key":"2026062312011995500_bnag016-B261","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCULATIONAHA.122.062349","article-title":"Genetic risk of primary aldosteronism and its contribution to hypertension: a cross-ancestry meta-analysis of genome-wide association studies","volume":"147","author":"Naito","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"2026062312011995500_bnag016-B262","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/js.2017-00134","article-title":"Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals","volume":"1","author":"Omata","year":"2017","journal-title":"J Endocr Soc"},{"issue":"9","key":"2026062312011995500_bnag016-B263","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molmed.2020.05.005","article-title":"Genetic and genomic mechanisms of primary aldosteronism","volume":"26","author":"Fernandes-Rosa","year":"2020","journal-title":"Trends Mol Med"},{"issue":"21","key":"2026062312011995500_bnag016-B264","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.3390\/cancers13215312","article-title":"Circulating microRNAs as diagnostic markers in primary aldosteronism","volume":"13","author":"MacKenzie","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2026062312011995500_bnag016-B265","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/HYPERTENSIONAHA.124.23418","article-title":"Circulating miRNAs and machine learning for lateralizing primary aldosteronism","volume":"81","author":"V\u00e9kony","year":"2024","journal-title":"Hypertension"},{"issue":"17","key":"2026062312011995500_bnag016-B266","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.3390\/cancers13174313","article-title":"KCNJ5 somatic mutations in aldosterone-producing adenoma are associated with a greater recovery of arterial stiffness","volume":"13","author":"Chang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"Supplement_1","key":"2026062312011995500_bnag016-B267","doi-asserted-by":"crossref","first-page":"bvae163.560","DOI":"10.1210\/jendso\/bvae163.560","article-title":"8310 CACNA1D- and KCNJ5-mutant aldosterone-producing adenomas (APAs) have opposite 2-year clinical outcomes from adrenalectomy: prospective trial findings explained by different cells-of-origin","volume":"8","author":"Laycock","year":"2024","journal-title":"J Endocr Soc"},{"issue":"4","key":"2026062312011995500_bnag016-B268","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"issue":"12","key":"2026062312011995500_bnag016-B269","doi-asserted-by":"crossref","first-page":"e12158","DOI":"10.1002\/jev2.12158","article-title":"Urinary extracellular vesicles: assessment of pre-analytical variables and development of a quality control with focus on transcriptomic biomarker research","volume":"10","author":"Barreiro","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"Suppl 3","key":"2026062312011995500_bnag016-B270","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1097\/01.hjh.0000941036.83712.a7","article-title":"Transcriptomic analysis of urinary extracellular vesicles in hypertensive patients with primary aldosteronism","volume":"41","author":"Mango","year":"2023","journal-title":"J Hypertension"},{"key":"2026062312011995500_bnag016-B271","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/01.hjh.0000467652.92919.31","article-title":"Detection of free-circulating DNA in patients with aldosterone producing adenoma","volume":"33","author":"Cangiano","year":"2015","journal-title":"J Hypertension"},{"issue":"3","key":"2026062312011995500_bnag016-B272","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01102","article-title":"MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex","volume":"62","author":"Robertson","year":"2013","journal-title":"Hypertension"},{"key":"2026062312011995500_bnag016-B273","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fendo.2019.00739","article-title":"Circulating miRNA expression profiling in primary aldosteronism","volume":"10","author":"Decmann","year":"2019","journal-title":"Front Endocrinol"},{"issue":"2","key":"2026062312011995500_bnag016-B274","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1210\/clinem\/dgaf408","article-title":"The significance of high expression of circulating miR-222-3p in patients with unilateral primary aldosteronism","volume":"111","author":"Okamoto","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"7164","key":"2026062312011995500_bnag016-B275","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature06258","article-title":"A second generation human haplotype map of over 3.1 million SNPs","volume":"449","author":"Frazer","year":"2007","journal-title":"Nature"},{"issue":"7","key":"2026062312011995500_bnag016-B276","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/biomedicines11071934","article-title":"Diagnostic accuracy of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for the subtyping of primary aldosteronism","volume":"11","author":"Araujo-Castro","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"2026062312011995500_bnag016-B277","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00259-022-05957-9","article-title":"First-in-human evaluation of [18F]CETO: a novel tracer for adrenocortical tumours","volume":"50","author":"Silins","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"2026062312011995500_bnag016-B278","doi-asserted-by":"crossref","first-page":"bvad114.668","DOI":"10.1210\/jendso\/bvad114.668","article-title":"FRI156 novel radiolabeled ligand, para-chloro-2-[(18)F]fluoroethyletomidate (CETO) is equivalent to [11C]metomidate-PET (MTO) for the lateralisation of primary aldosteronism (PA)","volume":"7","author":"Goodchild","year":"2023","journal-title":"J Endocr Soc"},{"issue":"1","key":"2026062312011995500_bnag016-B279","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/HYPERTENSIONAHA.124.23398","article-title":"Evolutionary characteristics in primary aldosteronism patients","volume":"82","author":"Gao","year":"2025","journal-title":"Hypertension"},{"issue":"9","key":"2026062312011995500_bnag016-B280","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/RLU.0000000000006014","article-title":"First-in-human evaluation of [18 F]AldoView: a highly selective PET tracer for aldosterone synthase imaging in primary aldosteronism","volume":"50","author":"Long","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"6","key":"2026062312011995500_bnag016-B281","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MOU.0000000000001040","article-title":"Adrenal functional imaging\u2014which marker for which indication?","volume":"32","author":"Werner","year":"2022","journal-title":"Curr Opin Urol"},{"issue":"3","key":"2026062312011995500_bnag016-B282","first-page":"97","article-title":"NP-59 scintigraphy for primary aldosteronism lateralization in a patient with polycystic kidney disease","volume":"9","author":"Fischer","year":"2023","journal-title":"AACE Clin Case Rep"},{"issue":"3","key":"2026062312011995500_bnag016-B283","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12020-020-02474-3","article-title":"(11)C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature","volume":"70","author":"Chen Cardenas","year":"2020","journal-title":"Endocrine"},{"issue":"1","key":"2026062312011995500_bnag016-B284","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13550-024-01109-2","article-title":"Radiation dosimetry of para-chloro-2-[(18)F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging","volume":"14","author":"Silins","year":"2024","journal-title":"EJNMMI Res"},{"key":"2026062312011995500_bnag016-B285","first-page":"606","article-title":"Identification of aldosterone-producing adrenal adenomas using [(68)Ga]Ga-Pentixafor PET\/CT in an Australian Cohort","volume":"67","author":"Ng","year":"2026","journal-title":"J Nucl Med"},{"issue":"1","key":"2026062312011995500_bnag016-B286","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13550-024-01125-2","article-title":"Clinical value of (68)Ga-pentixafor PET\/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study","volume":"14","author":"Zuo","year":"2024","journal-title":"EJNMMI Res"},{"issue":"13","key":"2026062312011995500_bnag016-B287","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1021\/acs.jmedchem.1c00539","article-title":"Development of [(18)F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of primary hyperaldosteronism","volume":"64","author":"Sander","year":"2021","journal-title":"J Med Chem"},{"issue":"21","key":"2026062312011995500_bnag016-B288","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMc2507481","article-title":"Adrenal aldosterone synthase expression imaging in primary aldosteronism","volume":"393","author":"\u00c5rstad","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"2026062312011995500_bnag016-B289","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1677\/JME-08-0144","article-title":"Corticosteroid receptors, macrophages and cardiovascular disease","volume":"42","author":"Rickard","year":"2009","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"2026062312011995500_bnag016-B290","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00004872-200208000-00002","article-title":"Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system","volume":"20","author":"Young","year":"2002","journal-title":"J Hypertens"},{"issue":"8","key":"2026062312011995500_bnag016-B291","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"2026062312011995500_bnag016-B292","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"14","key":"2026062312011995500_bnag016-B293","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"15","key":"2026062312011995500_bnag016-B294","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"2026062312011995500_bnag016-B295","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/jhh.2013.13","article-title":"Aldosterone levels and inflammatory stimulation in essential hypertensive patients","volume":"27","author":"Tzamou","year":"2013","journal-title":"J Hum Hypertens"},{"issue":"10","key":"2026062312011995500_bnag016-B296","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1097\/HJH.0000000000001041","article-title":"The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism","volume":"34","author":"Remde","year":"2016","journal-title":"J Hypertens"},{"issue":"2","key":"2026062312011995500_bnag016-B297","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12020-017-1348-8","article-title":"Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry","volume":"57","author":"Grotevendt","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"2026062312011995500_bnag016-B298","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjhyper.2005.08.019","article-title":"Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension","volume":"19","author":"Irita","year":"2006","journal-title":"Am J Hypertens"},{"issue":"2","key":"2026062312011995500_bnag016-B299","doi-asserted-by":"crossref","first-page":"229","DOI":"10.33549\/physiolres.932994","article-title":"Inflammatory markers in primary aldosteronism","volume":"65","author":"\u0160oml\u00f3ov\u00e1","year":"2016","journal-title":"Physiol Res"},{"issue":"3","key":"2026062312011995500_bnag016-B300","first-page":"152","article-title":"Increased glycoprotein acetylation is associated with high cardiac event rates: analysis using coronary computed tomography angiography","volume":"20","author":"An","year":"2018","journal-title":"Anatol J Cardiol"},{"issue":"1","key":"2026062312011995500_bnag016-B301","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12967-017-1321-6","article-title":"Glyca, a novel biomarker of systemic inflammation and cardiovascular disease risk","volume":"15","author":"Connelly","year":"2017","journal-title":"J Transl Med"},{"issue":"5","key":"2026062312011995500_bnag016-B302","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/joim.12953","article-title":"Glyca, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis","volume":"286","author":"Gruppen","year":"2019","journal-title":"J Intern Med"},{"issue":"6","key":"2026062312011995500_bnag016-B303","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/HYPERTENSIONAHA.119.13735","article-title":"Concentration of branched-chain amino acids is a strong risk marker for incident hypertension","volume":"74","author":"Flores-Guerrero","year":"2019","journal-title":"Hypertension"},{"issue":"4","key":"2026062312011995500_bnag016-B304","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1373\/clinchem.2015.251710","article-title":"Plasma branched-chain amino acids and incident cardiovascular disease in the PREDIMED trial","volume":"62","author":"Ruiz-Canela","year":"2016","journal-title":"Clin Chem"},{"issue":"10","key":"2026062312011995500_bnag016-B305","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/HJH.0b013e32833d0177","article-title":"Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients","volume":"28","author":"Stehr","year":"2010","journal-title":"J Hypertens"},{"issue":"12","key":"2026062312011995500_bnag016-B306","doi-asserted-by":"crossref","first-page":"bvaa153","DOI":"10.1210\/jendso\/bvaa153","article-title":"A multicenter study of neutrophil-to-lymphocyte ratio in primary aldosteronism","volume":"4","author":"Libianto","year":"2020","journal-title":"J Endocr Soc"},{"issue":"5","key":"2026062312011995500_bnag016-B307","doi-asserted-by":"crossref","first-page":"e1967","DOI":"10.1210\/clinem\/dgz306","article-title":"Arterial Wall Inflammation and increased hematopoietic activity in patients with primary aldosteronism","volume":"105","author":"van der Heijden","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026062312011995500_bnag016-B308","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, inflammation, immune system, and hypertension","volume":"34","author":"Ferreira","year":"2021","journal-title":"Am J Hypertens"},{"issue":"7","key":"2026062312011995500_bnag016-B309","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/cvr\/cvy092","article-title":"The mineralocorticoid receptor as a modulator of innate immunity and atherosclerosis","volume":"114","author":"van der Heijden","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2026062312011995500_bnag016-B310","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1074\/jbc.M116.739243","article-title":"Mineralocorticoid receptor deficiency in macrophages inhibits atherosclerosis by affecting foam cell formation and efferocytosis","volume":"292","author":"Shen","year":"2017","journal-title":"J Biol Chem"},{"issue":"11","key":"2026062312011995500_bnag016-B311","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1161\/ATVBAHA.121.316929","article-title":"Myeloid mineralocorticoid receptor transcriptionally regulates P-selectin glycoprotein ligand-1 and promotes monocyte trafficking and atherosclerosis","volume":"41","author":"Man","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026062312011995500_bnag016-B312","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2014.04.005","article-title":"Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease","volume":"91","author":"Bene","year":"2014","journal-title":"Steroids"},{"issue":"10","key":"2026062312011995500_bnag016-B313","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/CIRCRESAHA.116.310480","article-title":"T-Cell mineralocorticoid receptor controls blood pressure by regulating interferon-gamma","volume":"120","author":"Sun","year":"2017","journal-title":"Circ Res"},{"key":"2026062312011995500_bnag016-B314","doi-asserted-by":"crossref","first-page":"1428054","DOI":"10.3389\/fimmu.2024.1428054","article-title":"Sex-dependent modulation of T and NK cells and gut microbiome by low sodium diet in patients with primary aldosteronism","volume":"15","author":"Nowotny","year":"2024","journal-title":"Front Immunol"},{"key":"2026062312011995500_bnag016-B315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fendo.2015.00153","article-title":"Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis","volume":"6","author":"Moss","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2026062312011995500_bnag016-B316","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/jhh.2014.11","article-title":"Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage","volume":"28","author":"Liu","year":"2014","journal-title":"J Hum Hypertens"},{"issue":"8","key":"2026062312011995500_bnag016-B317","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.jhh.1001403","article-title":"Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors","volume":"16","author":"Hlubock\u00e1","year":"2002","journal-title":"J Hum Hypertens"},{"issue":"10","key":"2026062312011995500_bnag016-B318","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"2026062312011995500_bnag016-B319","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ahj.2008.10.010","article-title":"Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations","volume":"157","author":"Povsic","year":"2009","journal-title":"Am Heart J"},{"issue":"10","key":"2026062312011995500_bnag016-B320","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/jc.2011-1135","article-title":"Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis","volume":"96","author":"Wu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2026062312011995500_bnag016-B321","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair","volume":"111","author":"Schmidt-Lucke","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"2026062312011995500_bnag016-B322","doi-asserted-by":"crossref","first-page":"597","DOI":"10.33549\/physiolres.930912","article-title":"Biochemical markers of endothelial dysfunction in patients with endocrine and essential hypertension","volume":"55","author":"Petr\u00e1k","year":"2006","journal-title":"Physiol Res"},{"issue":"1","key":"2026062312011995500_bnag016-B323","doi-asserted-by":"crossref","first-page":"1470320321999491","DOI":"10.1177\/1470320321999491","article-title":"Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension","volume":"22","author":"Sang","year":"2021","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"3","key":"2026062312011995500_bnag016-B324","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/ijms26031008","article-title":"Extracellular vesicles as mediators of endothelial dysfunction in cardiovascular diseases","volume":"26","author":"Jimenez-Trinidad","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2026062312011995500_bnag016-B325","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/HYPERTENSIONAHA.121.17136","article-title":"Characterization of circulating extracellular vesicle surface antigens in patients with primary aldosteronism","volume":"78","author":"Burrello","year":"2021","journal-title":"Hypertension"},{"issue":"12","key":"2026062312011995500_bnag016-B326","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"issue":"7","key":"2026062312011995500_bnag016-B327","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jch.13585","article-title":"Hypertension with primary aldosteronism is associated with increased carotid intima-media thickness and endothelial dysfunction","volume":"21","author":"Demirkiran","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"2026062312011995500_bnag016-B328","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/HYPERTENSIONAHA.114.05001","article-title":"Effect of aldosterone-producing adenoma on endothelial function and rho-associated kinase activity in patients with primary aldosteronism","volume":"65","author":"Matsumoto","year":"2015","journal-title":"Hypertension"},{"issue":"23","key":"2026062312011995500_bnag016-B329","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","article-title":"Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism","volume":"109","author":"Nishizaka","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"2026062312011995500_bnag016-B330","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40618-022-01888-2","article-title":"Evaluation of arterial stiffness and serum endocan levels in patients with primary aldosteronism with new-onset hypertension and long-term hypertension","volume":"46","author":"Can","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2026062312011995500_bnag016-B331","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"2026062312011995500_bnag016-B332","doi-asserted-by":"crossref","first-page":"e004815","DOI":"10.1161\/CIRCIMAGING.116.004815","article-title":"Cardiac remodeling in patients with primary and secondary aldosteronism: a tissue Doppler study","volume":"9","author":"Cesari","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"2026062312011995500_bnag016-B333","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/HYPERTENSIONAHA.122.19134","article-title":"Cardiac structure and function across the spectrum of aldosteronism: the atherosclerosis risk in communities study","volume":"79","author":"Brown","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"2026062312011995500_bnag016-B334","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"2026062312011995500_bnag016-B335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fcvm.2014.00007","article-title":"Electrical and myocardial remodeling in primary aldosteronism","volume":"1","author":"Curione","year":"2014","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"2026062312011995500_bnag016-B336","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/a-2348-4468","article-title":"NT-pro-BNP level is related to left ventricular remodeling in patients with primary aldosteronism","volume":"132","author":"Wu","year":"2024","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026062312011995500_bnag016-B337","doi-asserted-by":"crossref","first-page":"799174","DOI":"10.3389\/fendo.2022.799174","article-title":"Elevated myoglobin in patients with primary aldosteronism: a cross-sectional study","volume":"13","author":"Kang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2026062312011995500_bnag016-B338","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/HJH.0000000000001383","article-title":"Plasma galectin-3 concentrations in patients with primary aldosteronism","volume":"35","author":"van den Berg","year":"2017","journal-title":"J Hypertens"},{"issue":"2","key":"2026062312011995500_bnag016-B339","first-page":"599","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (review)","volume":"41","author":"Dong","year":"2018","journal-title":"Int J Mol Med"},{"key":"2026062312011995500_bnag016-B340","doi-asserted-by":"crossref","first-page":"1567876","DOI":"10.3389\/fendo.2025.1567876","article-title":"Myocardial fibrosis in primary aldosteronism","volume":"16","author":"Chen","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026062312011995500_bnag016-B341","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41440-023-01482-w","article-title":"Non-invasive left ventricular pressure-strain loop study on cardiac fibrosis in primary aldosteronism: a comparative study with cardiac magnetic resonance imaging","volume":"47","author":"Chen","year":"2024","journal-title":"Hypertens Res"},{"issue":"4","key":"2026062312011995500_bnag016-B342","doi-asserted-by":"crossref","first-page":"e028146","DOI":"10.1161\/JAHA.122.028146","article-title":"Markers of kidney tubular function deteriorate while those of kidney tubule health improve in primary aldosteronism after targeted treatments","volume":"12","author":"Wu","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2026062312011995500_bnag016-B343","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/cen.14434","article-title":"Association between plasma aldosterone and markers of tubular and glomerular damage in primary aldosteronism","volume":"94","author":"Nakamura","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026062312011995500_bnag016-B344","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"2026062312011995500_bnag016-B345","doi-asserted-by":"crossref","first-page":"574151","DOI":"10.3389\/fendo.2020.574151","article-title":"Primary aldosteronism and bone metabolism: a systematic review and meta-analysis","volume":"11","author":"Shi","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026062312011995500_bnag016-B346","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2017-02043","article-title":"Lower trabecular bone score in patients with primary aldosteronism: human skeletal deterioration by aldosterone excess","volume":"103","author":"Kim","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026062312011995500_bnag016-B347","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/clinem\/dgaa123","article-title":"Disentangling the relationships between the renin\u2013angiotensin\u2013aldosterone system, calcium physiology, and risk for kidney stones","volume":"105","author":"Bayomy","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026062312011995500_bnag016-B348","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism","volume":"30","author":"Maniero","year":"2012","journal-title":"J Hypertens"},{"issue":"1","key":"2026062312011995500_bnag016-B349","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03348648","article-title":"Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism","volume":"15","author":"Miyamori","year":"1992","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2026062312011995500_bnag016-B350","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/s41440-023-01413-9","article-title":"Utility of 18-hydroxycortisol and 18-oxocortisol: potential markers of aldosterone-producing adenomas","volume":"46","author":"Ozeki","year":"2023","journal-title":"Hypertens Res"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnag016\/68391380\/bnag016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnag016\/68391380\/bnag016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:02:22Z","timestamp":1782230542000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article\/doi\/10.1210\/endrev\/bnag016\/8694038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":350,"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnag016","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"bnag016"}}